Summary
Murine models of systemic lupus erythematosus provide fertile research systems for the pathogenesis and therapy of systemic autoimmune disease. Their phenotypes span the broad range of clinical manifestations of human lupus and consist of both spontaneous and experimentally induced disease in both inbred and targeted mutant animals. This chapter contrasts the clinical characteristics of these various models, providing an outline for the use and analysis of these in vivo autoimmune systems.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Boumpas, D. T., Austin, H. A., 3rd, Fessler, B. J., Balow, J. E., Klippel, J. H., and Lockshin, M. D. (1995) Systemic lupus erythematosus: emerging concepts. Part 1: Renal, neuropsychiatric, cardiovascular, pulmonary, and hematologic disease. Ann. Intern. Med. 122, 940ā950.
Boumpas, D. T., Fessler, B. J., Austin, H. A., 3rd, Balow, J. E., Klippel, J. H., and Lockshin, M. D. (1995) Systemic lupus erythematosus: emerging concepts. Part 2: Dermatologic and joint disease, the antiphospholipid antibody syndrome, pregnancy and hormonal therapy, morbidity and mortality, and pathogenesis. Ann. Intern. Med. 123, 42ā53.
Burkhardt, H. and Kalden, J. R. (1997) Animal models of autoimmune diseases. Rheumatol. Int. 17, 91ā99.
Stoll, M. L. and Gavalchin, J. (2000) Systemic lupus erythematosus-messages from experimental models. Rheumatology 39, 18ā27.
Jones, D. R. (1993) Canine systemic lupus erythematosus: new insights and their implications. J. Comp. Pathol. 108, 215ā228.
Lusson, D., Billiemaz, B., and Chabanne, J. L. (1999) Circulating lupus anticoagulant and probable systemic lupus erythematosus in a cat. J. Feline Med. Surg. 1, 193ā196.
Theofilopoulos, A. N. and Dixon, F. J. (1985) Murine models of systemic lupus erythematosus. Adv. Immunol. 37, 269ā390.
Cohen, P. L. and Eisenberg, R. A. (1991) Lpr and gld: single gene models of systemic autoimmunity and lymphoproliferative disease. Annu. Rev. Immunol. 9, 243ā269.
Brey, R. L., Sakic, B., Szechtman, H., and Denburg, J. A. (1997) Animal models for nervous system disease in systemic lupus erythematosus. Ann. N. Y. Acad. Sci. 823, 97ā106.
Furukawa, F. (1997) Animal models of cutaneous lupus erythematosus and lupus erythematosus photosensitivity. Lupus 6, 193ā202.
Peng, S. L. and Craft, J. (1997) The regulation of murine lupus. Ann. N. Y. Acad. Sci. 815, 128ā138.
Scofield, R. H. and James, J. A. (1999) Immunization as a model for systemic lupus erythematosus. Sem. Arthritis Rheum. 29, 140ā147.
Izui, S., Ibnou-Zekri, N., Fossati-Jimack, L., and Iwamoto, M. (2000) Lessons from BXSB and related mouse models. Int. Rev. Immunol. 19, 447ā472.
Kono, D. H. and Theofilopoulos, A. N. (2000) Genetics of systemic autoimmunity in mouse models of lupus. Int. Rev. Immunol. 19, 367ā387.
Nose, M., Nishihara, M., and Fujii, H. (2000) Genetic basis of the complex pathological manifestations of collagen disease: lessons from MRL/lpr and related mouse models. Int. Rev. Immunol. 19, 473ā498.
Shlomchik, M. J., Craft, J. E., and Mamula, M. J. (2001) From T to B and back again: positive feedback in systemic autoimmune disease. Nat. Rev. Immunol. 1, 147ā153.
Bielschowsky, M., Helyer, B. J., and Howie, J. B. (1959) Spontaneous haemolytic anemia in mice of the NZB/BL strain. Proc. Univ. Otago Med. Sch. 37, 9.
Bielschowsky, M. and Goodall, C. M. (1970) Origin of inbred NZ mouse strains. Cancer Res. 30, 834ā836.
Hall, W. H. and Simpson, L. O. (1975) The origins of some hitherto undescribed inbred mouse strains. Lab. Animals 9, 139ā142.
Beck, J. A., Lloyd, S., Hafezparast, M., Lennon-Pierce, M., Eppig, J. T., Festing, M. F., et al. (2000) Genealogies of mouse inbred strains. Nat. Genet. 24, 23ā25.
Jackson Laboratory website, http://jaxmice.jax.org/jaxmice-cgi/jaxmicedb.cgi?objtype=pricedetail&stock=001058&dest=N.
Burnet, F. M. and Holmes, M. C. (1965) The natural history of the NZB/NZW F1 hybrid mouse: a laboratory model of systemic lupus erythematosus. Aust. Ann. Med. 14, 185ā191.
Chiang, B. L., Bearer, E., Ansari, A., Dorshkind, K., and Gershwin, M. E. (1990) The BM12 mutation and autoantibodies to dsDNA in NZB.H-2bm12 mice. J. Immunol. 145, 94ā101.
Rudofsky, U. H., Evans, B. D., Balaban, S. L., Mottironi, V. D., and Gabrielsen, A. E. (1993) Differences in expression of lupus nephritis in New Zealand mixed H-2z homozygous inbred strains of mice derived from New Zealand black and New Zealand white mice. Origins and initial characterization. Lab. Invest. 68, 419ā426.
Morel, L., Rudofsky, U. H., Longmate, J. A., Schiffenbauer, J., and Wakeland, E. K. (1994) Polygenic control of susceptibility to murine systemic lupus erythematosus. Immunity 1, 219ā229.
Helyer, B. J. and Howie, J. B. (1963) Renal disease associated with positive lupus erythematosus test in a cross-bred strain of mice. Nature 197, 197.
Hicks, J. D. and Burnet, F. M. (1966) Renal lesions in the āauto-immuneā mouse strains NZB and F1 NZBxNZW. J. Pathol. Bacteriol. 91, 467ā476.
Hicks, J. D. (1966) Vascular changes in the kidneys of NZB mice and F1 NZBxNZW hybrids. J. Pathol. Bacteriol. 91, 479ā486.
Russell, P. J., Hicks, J. D., and Burnet, F. M. (1966) Cyclophosphamide treatment of kidney disease in (NZB Ć NZW) F1 mice. Lancet 1, 1280ā1284.
Miyasato, F., Manaligod, J. R., and Pollak, V. E. (1967) Auto-immune disease in NZB and NZB-NZW F1 mice. Natural history and pathology. Arch. Pathol. Lab. Med. 83, 20ā30.
Russell, P. J. and Hicks, J. D. (1968) Cyclophosphamide treatment of renal disease in (NZB Ć NZW) F1 hybrid mice. Lancet 1, 440ā441.
Deshmukh, U. S., Lewis, J. E., Gaskin, F., Dhakephalkar, P. K., Kannapell, C. C., Waters, S. T., et al. (2000) Ro60 peptides induce antibodies to similar epitopes shared among lupus-related autoantigens. J. Immunol. 164, 6655ā6661.
Monneaux, F., Dumortier, H., Steiner, G., Briand, J. P., and Muller, S. (2001) Murine models of systemic lupus erythematosus: B and T cell responses to spliceosomal ribonucleoproteins in MRL/Fas(lpr) and (NZB Ć NZW) F1 lupus mice. Int. Immunol. 13, 1155ā1163.
Suen, J. L., Wu, C. H., Chen, Y. Y., Wu, W. M., and Chiang, B. L. (2001) Characterization of self-T-cell response and antigenic determinants of U1A protein with bone marrow-derived dendritic cells in NZB Ć NZW F1 mice. Immunology 103, 301ā309.
Matsuura, E., Igarashi, Y., Yasuda, T., Triplett, D. A., and Koike, T. (1994) Anticardiolipin antibodies recognize Ī²2-glycoprotein I structure altered by interacting with an oxygen modified solid phase surface. J. Exp. Med. 179, 457ā462.
Haruta, K., Kobayashi, S., Hirose, S., Horiai, A., Ohyanagi, M., Tanaka, M., et al. (1998) Monoclonal anti-cardiolipin antibodies from New Zealand black Ć New Zealand white F1 mice react to thrombomodulin. J. Immunol. 160, 253ā258.
Boros, P., Chen, J. M., Bona, C., and Unkeless, J. C. (1990) Autoimmune mice make anti-FcĪ³ receptor antibodies. J. Exp. Med. 171, 1581ā1595.
Eilat, D., Schechter, A. N., and Steinberg, A. D. (1976) Antibodies to native tRNA in NZB/NZW mice. Nature 259, 141ā143.
Boackle, S. A., Holers, V. M., Chen, X., Szakonyi, G., Karp, D. R., Wakeland, E. K., et al. (2001) Cr2, a candidate gene in the murine Sle1c lupus susceptibility locus, encodes a dysfunctional protein. Immunity 15, 775ā785.
Rozzo, S. J., Allard, J. D., Choubey, D., Vyse, T. J., Izui, S., Peltz, G., et al. (2001) Evidence for an interferon-inducible gene, Ifi202, in the susceptibility to systemic lupus. Immunity 15, 435ā443.
Hirose, S., Nagasawa, R., Sekikawa, I., Hamaoki, M., Ishida, Y., Sato, H., et al. (1983) Enhancing effect of H-2-linked NZW gene(s) on the autoimmune traits of (NZB Ć NZW) F1 mice. J. Exp. Med. 158, 228ā233.
Kotzin, B. L. and Palmer, E. (1987) The contribution of NZW genes to lupus-like disease in (NZB Ć NZW) F1 mice. J. Exp. Med. 165, 1237ā1251.
Schiffenbauer, J., McCarthy, D. M., Nygard, N. R., Woulfe, S. L., Didier, D. K., and Schwartz, B. D. (1989) A unique sequence of the NZW I-EĪ² chain and its possible contribution to autoimmunity in the (NZB Ć NZW) F1 mouse. J. Exp. Med. 170, 971ā984.
Babcock, S. K., Appel, V. B., Schiff, M., Palmer, E., and Kotzin, B. L. (1989) Genetic analysis of the imperfect association of H-2 haplotype with lupus-like autoimmune disease. Proc. Natl. Acad. Sci. USA 86, 7552ā7555.
Ibnou-Zekri, N., Iwamoto, M., Fossati, L., McConahey, P. J., and Izui, S. (1997) Role of the major histocompatibility complex class II Ea gene in lupus susceptibility in mice. Proc. Natl. Acad. Sci. U S A 94, 14,654ā14,659.
Vyse, T. J., Rozzo, S. J., Drake, C. G., Appel, V. B., Lemeur, M., Izui, S., et al. (1998) Contributions of Ea(z) and Eb(z) MHC genes to lupus susceptibility in New Zealand mice. J. Immunol. 160, 2757ā2766.
Vyse, T. J., Halterman, R. K., Rozzo, S. J., Izui, S., and Kotzin, B. L. (1999) Control of separate pathogenic autoantibody responses marks MHC gene contributions to murine lupus. Proc. Natl. Acad. Sci. USA 96, 8098ā8103.
Jacob, C. O. and McDevitt, H. O. (1988) Tumour necrosis factor-Ī± in murine autoimmune ālupusā nephritis. Nature 331, 356ā358.
Jongeneel, C. V., Acha-Orbea, H., and Blankenstein, T. (1990) A polymorphic microsatellite in the tumor necrosis factor Ī± promoter identifies an allele unique to the NZW mouse strain. J. Exp. Med. 171, 2141ā2146.
Knight, J. G. and Adams, D. D. (1978) Three genes for lupus nephritis in NZB Ć NZW mice. J. Exp. Med. 147, 1653ā1660.
Ozaki, S., Honda, H., Maruyama, N., Hirose, S., Hamaoki, M., Sato, H., et al. (1983) Genetic regulation of erythrocyte autoantibody production in New Zealand black mice. Immunogenetics 18, 241ā254.
Drake, C. G., Babcock, S. K., Palmer, E., and Kotzin, B. L. (1994) Genetic analysis of the NZB contribution to lupus-like autoimmune disease in (NZB Ć NZW) F1 mice. Proc. Natl. Acad. Sci. USA 91, 4062ā4066.
Kono, D. H., Burlingame, R. W., Owens, D. G., Kuramochi, A., Balderas, R. S., Balomenos, D., et al. (1994) Lupus susceptibility loci in New Zealand mice. Proc. Natl. Acad. Sci. USA 91, 10,168ā10,172.
Rahman, Z. S., Tin, S. K., Buenaventura, P. N., Ho, C. H., Yap, E. P., Yong, R. Y., et al. (2002) A novel susceptibility locus on chromosome 2 in the (New Zealand black Ć New Zealand white) F1 hybrid mouse model of systemic lupus erythematosus. J. Immunol. 168, 3042ā3049.
Adelman, N. E., Watling, D. L., and McDevitt, H. O. (1983) Treatment of (NZB Ć NZW) F1 disease with anti-I-A monoclonal antibodies. J. Exp. Med. 158, 1350ā1355.
Wofsy, D. and Seaman, W. E. (1985) Successful treatment of autoimmunity in NZB/NZW F1 mice with monoclonal antibody to L3T4. J. Exp. Med. 161, 378ā391.
Datta, S. K., Patel, H., and Berry, D. (1987) Induction of a cationic shift in IgG anti-DNA autoantibodies. Role of T helper cells with classical and novel phenotypes in three murine models of lupus nephritis. J. Exp. Med. 165, 1252ā1268.
Tillman, D. M., Jou, N. T., Hill, R. J., and Marion, T. N. (1992) Both IgM and IgG anti-DNA antibodies are the products of clonally selective B cell stimulation in (NZB Ć NZW) F1 mice. J. Exp. Med. 176, 761ā779.
Friedmann, D., Yachimovich, N., Mostoslavsky, G., Pewzner-Jung, Y., Ben-Yehuda, A., Rajewsky, K., et al. (1999) Production of high affinity autoantibodies in autoimmune New Zealand black/New Zealand white F1 mice targeted with an anti-DNA heavy chain. J. Immunol. 162, 4406ā4416.
Kaliyaperumal, A., Mohan, C., Wu, W., and Datta, S. K. (1996) Nucleosomal peptide epitopes for nephritis-inducing T helper cells of murine lupus. J. Exp. Med. 183, 2459ā2469.
Kaliyaperumal, A., Michaels, M. A., and Datta, S. K. (1999) Antigen-specific therapy of murine lupus nephritis using nucleosomal peptides: tolerance spreading impairs pathogenic function of autoimmune T and B cells. J. Immunol. 162, 5775ā5783.
Kaliyaperumal, A., Michaels, M. A., and Datta, S. K. (2002) Naturally processed chromatin peptides reveal a major autoepitope that primes pathogenic T and B cells of lupus. J. Immunol. 168, 2530ā2537.
Wang, Y., Hu, Q., Madri, J. A., Rollins, S. A., Chodera, A., and Matis, L. A. (1996) Amelioration of lupus-like autoimmune disease in NZB/WF1 mice after treatment with a blocking monoclonal antibody specific for complement component C5. Proc. Natl. Acad. Sci. USA 93, 8563ā8568.
Clynes, R., Dumitru, C., and Ravetch, J. V. (1998) Uncoupling of immune complex formation and kidney damage in autoimmune glomerulonephritis. Science 279, 1052ā1054.
Pritchard, N. R., Cutler, A. J., Uribe, S., Chadban, S. J., Morley, B. J., and Smith, K. G. (2000) Autoimmune-prone mice share a promoter haplotype associated with reduced expression and function of the Fc receptor FcĪ³RII. Curr. Biol. 10, 227ā230.
Finck, B. K., Linsley, P. S., and Wofsy, D. (1994) Treatment of murine lupus with CTLA4Ig. Science 265, 1225ā1227.
Early, G. S., Zhao, W., and Burns, C. M. (1996) Anti-CD40 ligand antibody treatment prevents the development of lupus-like nephritis in a subset of New Zealand black Ć New Zealand white mice. Response correlates with the absence of an anti-antibody response. J. Immunol. 157, 3159ā3164.
Mihara, M., Tan, I., Chuzhin, Y., Reddy, B., Budhai, L., Holzer, A., et al. (2000) CTLA4Ig inhibits T cell-dependent B-cell maturation in murine systemic lupus erythematosus. J. Clin. Invest. 106, 91ā101.
Daikh, D. I. and Wofsy, D. (2001) Cutting edge: reversal of murine lupus nephritis with CTLA4Ig and cyclophosphamide. J. Immunol. 166, 2913ā2916.
Wang, X., Huang, W., Mihara, M., Sinha, J., and Davidson, A. (2002) Mechanism of action of combined short-term CTLA4Ig and anti-CD40 ligand in murine systemic lupus erythematosus. J. Immunol. 168, 2046ā2053.
Gilkeson, G. S., Pippen, A. M., and Pisetsky, D. S. (1995) Induction of cross-reactive anti-dsDNA antibodies in preautoimmune NZB/NZW mice by immunization with bacterial DNA. J. Clin. Invest. 95, 1398ā1402.
Gilkeson, G. S., Ruiz, P., Pippen, A. M., Alexander, A. L., Lefkowith, J. B., and Pisetsky, D. S. (1996) Modulation of renal disease in autoimmune NZB/NZW mice by immunization with bacterial DNA. J. Exp. Med. 183, 1389ā1397.
Riemekasten, G., Kawald, A., Weiss, C., Meine, A., Marell, J., Klein, R., et al. (2001) Strong acceleration of murine lupus by injection of the SmD1(83ā119) peptide. Arthritis Rheum. 44, 2435ā2445.
Hahn, B. H. and Ebling, F. M. (1983) Suppression of NZB/NZW murine nephritis by administration of a syngeneic monoclonal antibody to DNA. Possible role of anti-idiotypic antibodies. J. Clin. Invest. 71, 1728ā1736.
Singh, R. R., Kumar, V., Ebling, F. M., Southwood, S., Sette, A., Sercarz, E. E., et al. (1995) T cell determinants from autoantibodies to DNA can upregulate autoimmunity in murine systemic lupus erythematosus. J. Exp. Med. 181, 2017ā2027.
Singh, R. R., Ebling, F. M., Sercarz, E. E., and Hahn, B. H. (1995) Immune tolerance to autoantibody-derived peptides delays development of autoimmunity in murine lupus. J. Clin. Invest. 96, 2990ā2996.
Hahn, B. H., Singh, R. R., Wong, W. K., Tsao, B. P., Bulpitt, K., and Ebling, F. M. (2001) Treatment with a consensus peptide based on amino acid sequences in autoantibodies prevents T cell activation by autoantigens and delays disease onset in murine lupus. Arthritis Rheum. 44, 432ā441.
Beger, E., Deocharan, B., Edelman, M., Erblich, B., Gu, Y., and Putterman, C. (2002) A peptide DNA surrogate accelerates autoimmune manifestations and nephritis in lupus-prone mice. J. Immunol. 168, 3617ā3626.
Jacob, C. O., van der Meide, P. H., and McDevitt, H. O. (1987) In vivo treatment of (NZB Ć NZW) F1 lupus-like nephritis with monoclonal antibody to Ī³ interferon. J. Exp. Med. 166, 798ā803.
Ozmen, L., Roman, D., Fountoulakis, M., Schmid, G., Ryffel, B., and Garotta, G. (1995) Experimental therapy of systemic lupus erythematosus: the treatment of NZB/W mice with mouse soluble interferon-Ī³ receptor inhibits the onset of glomerulonephritis. Eur. J. Immunol. 25, 6ā12.
Haas, C., Ryffel, B., and Le Hir, M. (1998) IFN-Ī³ receptor deletion prevents autoantibody production and glomerulonephritis in lupus-prone (NZB Ć NZW) F1 mice. J. Immunol. 160, 3713ā3718.
Kontoyiannis, D. and Kollias, G. (2000) Accelerated autoimmunity and lupus nephritis in NZB mice with an engineered heterozygous deficiency in tumor necrosis factor. Eur. J. Immunol. 30, 2038ā2047.
Altman, A., Theofilopoulos, A. N., Weiner, R., Katz, D. H., and Dixon, F. J. (1981) Analysis of T cell function in autoimmune murine strains. Defects in production and responsiveness to interleukin 2. J. Exp. Med. 154, 791ā808.
Nakajima, A., Hirose, S., Yagita, H., and Okumura, K. (1997) Roles of IL-4 and IL-12 in the development of lupus in NZB/W F1 mice. J. Immunol. 158, 1466ā1472.
Santiago, M. L., Fossati, L., Jacquet, C., Muller, W., Izui, S., and Reininger, L. (1997) Interleukin-4 protects against a genetically linked lupus-like autoimmune syndrome. J. Exp. Med. 185, 65ā70.
Finck, B. K., Chan, B., and Wofsy, D. (1994) Interleukin 6 promotes murine lupus in NZB/NZW F1 mice. J. Clin. Invest. 94, 585ā591.
Ishida, H., Muchamuel, T., Sakaguchi, S., Andrade, S., Menon, S., and Howard, M. (1994) Continuous administration of anti-interleukin 10 antibodies delays onset of autoimmunity in NZB/W F1 mice. J. Exp. Med. 179, 305ā310.
Goldings, E. A., Cohen, P. L., McFadden, S. F., Ziff, M., and Vitetta, E. S. (1980) Defective B cell tolerance in adult (NZB Ć NZW) F1 mice. J. Exp. Med. 152, 730ā735.
Brooks, M. S. and Aldo-Benson, M. (1986) Defects in antigen-specific immune tolerance in continuous B cell lines from autoimmune mice. J. Clin. Invest. 78, 784ā789.
Klinman, D. M. and Steinberg, A. D. (1987) Systemic autoimmune disease arises from polyclonal B cell activation. J. Exp. Med. 165,, 1755ā1760.
Klinman, D. M. (1990) Polyclonal B cell activation in lupus-prone mice precedes and predicts the development of autoimmune disease. J. Clin. Invest. 86, 1249ā1254.
Reininger, L., Radaszkiewicz, T., Kosco, M., Melchers, F., and Rolink, A. G. (1992) Development of autoimmune disease in SCID mice populated with long-term āin vitroā proliferating (NZB Ć NZW) F1 pre-B cells. J. Exp. Med. 176, 1343ā1353.
Murakami, M., Yoshioka, H., Shirai, T., Tsubata, T., and Honjo, T. (1995) Prevention of autoimmune symptoms in autoimmune-prone mice by elimination of B-1 cells. Int. Immunol. 7, 877ā882.
Reininger, L., Winkler, T. H., Kalberer, C. P., Jourdan, M., Melchers, F., and Rolink, A. G. (1996) Intrinsic B cell defects in NZB and NZW mice contribute to systemic lupus erythematosus in (NZB Ć NZW) F1 mice. J. Exp. Med. 184, 853ā861.
Cassese, G., Lindenau, S., de Boer, B., Arce, S., Hauser, A., Riemekasten, G., et al. (2001) Inflamed kidneys of NZB/W mice are a major site for the homeostasis of plasma cells. Eur. J. Immunol. 31, 2726ā2732.
Wellmann, U., Letz, M., Schneider, A., Amann, K., and Winkler, T. H. (2001) An Ig mu-heavy chain transgene inhibits systemic lupus erythematosus immunopathology in autoimmune (NZB Ć NZW) F1 mice. Int. Immunol. 13, 1461ā1469.
Ishikawa, S., Sato, T., Abe, M., Nagai, S., Onai, N., Yoneyama, H., et al. (2001) Aberrant high expression of B lymphocyte chemokine (BLC/CXCL13) by C11b+CD11c+ dendritic cells in murine lupus and preferential chemotaxis of B1 cells towards BLC. J. Exp. Med. 193, 1393ā1402.
Zeng, D., Lee, M. K., Tung, J., Brendolan, A., and Strober, S. (2000) Cutting edge: a role for CD1 in the pathogenesis of lupus in NZB/NZW mice. J. Immunol. 164, 5000ā5004.
Murphy, E. D. (1981) Lymphoproliferation (lpr) and other single-locus models for murine lupus, in Immunologic Defects in Laboratory Animals (Gershwin, M. E., and Merchant, B., eds.), Plenum Press, New York, Vol. 1, pp. 143ā173.
Izui, S., McConahey, P. J., and Dixon, F. J. (1978) Increased spontaneous polyclonal activation of B lymphocytes in mice with spontaneous autoimmune disease. J. Immunol. 121, 2213ā2219.
Andrews, B. S., Eisenberg, R. A., Theofilopoulos, A. N., Izui, S., Wilson, C. B., McConahey, P. J., et al. (1978) Spontaneous murine lupus-like syndromes. Clinical and immunopathological manifestations in several strains. J. Exp. Med. 148, 1198ā1215.
Dixon, F. J., Andrews, B. S., Eisenberg, R. A., McConahey, P. J., Theofilopoulos, A. N., and Wilson, C. B. (1978) Etiology and pathogenesis of a spontaneous lupus-like syndrome in mice. Arthritis Rheum. 21, S64āS67.
Murphy, E. D. and Roths, J. B. (1976) A single gene model for massive lyphoproliferation with immune complex disease in new mouse strain MRL. Proc. 16th Int. Cong. Hematol., 69.
Murphy, E. D. and Roths, J. B. (1978) New inbred strains. Mouse News Lett. 58, 51.
Burlingame, R. W., Rubin, R. L., Balderas, R. S., and Theofilopoulos, A. N. (1993) Genesis and evolution of antichromatin autoantibodies in murine lupus implicates T-dependent immunization with self antigen. J. Clin. Invest. 91, 1687ā1696.
Hang, L., Slack, J. H., Amundson, C., Izui, S., Theofilopoulos, A. N., and Dixon, F. J. (1983) Induction of murine autoimmune disease by chronic polyclonal B cell activation. J. Exp. Med. 157, 874ā883.
Vratsanos, G. S., Jung, S., Park, Y. M., and Craft, J. (2001) CD4(+) T cells from lupus-prone mice are hyperresponsive to T cell receptor engagement with low and high affinity peptide antigens: a model to explain spontaneous T cell activation in lupus. J. Exp. Med. 193, 329ā337.
Eisenberg, R. A., Craven, S. Y., Warren, R. W., and Cohen, P. L. (1987) Stochastic control of anti-Sm autoantibodies in MRL/Mp-lpr/lpr mice. J. Clin. Invest. 80, 691ā697.
Shlomchik, M. J., Marshak-Rothstein, A., Wolfowicz, C. B., Rothstein, T. L., and Weigert, M. G. (1987) The role of clonal selection and somatic mutation in autoimmunity. Nature 328, 805ā811.
Shlomchik, M. J., Aucoin, A. H., Pisetsky, D. S., and Weigert, M. G. (1987) Structure and function of anti-DNA autoantibodies derived from a single autoimmune mouse. Proc. Natl. Acad. Sci. USA 84, 9150ā9154.
Shlomchik, M., Mascelli, M., Shan, H., Radic, M. Z., Pisetsky, D., Marshak-Rothstein, A., et al. (1990) Anti-DNA antibodies from autoimmune mice arise by clonal expansion and somatic mutation. J. Exp. Med. 171, 265ā292.
Bloom, D. D., Davignon, J. L., Retter, M. W., Shlomchik, M. J., Pisetsky, D. S., Cohen, P. L., et al. (1993) V region gene analysis of anti-Sm hybridomas from MRL/Mp-lpr/lpr mice. J. Immunol. 150, 1591ā1610.
Bloom, D. D., Davignon, J. L., Cohen, P. L., Eisenberg, R. A., and Clarke, S. H. (1993) Overlap of the anti-Sm and anti-DNA responses of MRL/Mp-lpr/lpr mice. J. Immunol. 150, 1579ā1590.
Ishigatsubo, Y., Igarashi, T., Ohno, S., Ueda, A., Okubo, T., and Klinman, D. M. (1993) Cross-reactivity of IgM-and IgG-secreting B cells in autoimmune mice. Arthritis Rheum. 36, 1003ā1006.
Klinman, D. M., Dellacqua, D. K., Conover, J., and Huppi, K. (1993) VH family utilization by IgG anti-DNA-secreting lymphocytes derived from autoimmune MRL-lpr/lpr mice. Arthritis Rheum. 36, 561ā568.
Fatenejad, S., Brooks, W., Schwartz, A., and Craft, J. (1994) Pattern of anti-small nuclear ribonucleoprotein antibodies in MRL/Mp-lpr/lpr mice suggests that the intact U1 snRNP particle is their autoimmunogenic target. J. Immunol. 152, 5523ā5531.
Kita, Y., Sumida, T., Iwamoto, I., Yoshida, S., and Koike, T. (1994) V gene analysis of anti-cardiolipin antibodies from (NZW Ć BXSB) F1 mice. Immunology 82, 494ā501.
Shan, H., Shlomchik, M. J., Marshak-Rothstein, A., Pisetsky, D. S., Litwin, S., and Weigert, M. G. (1994) The mechanism of autoantibody production in an autoimmune MRL/lpr mouse. J. Immunol. 153, 5104ā5120.
Retter, M. W., Cohen, P. L., Eisenberg, R. A., and Clarke, S. H. (1996) Both Sm and DNA are selecting antigens in the anti-Sm B cell response in autoimmune MRL/lpr mice. J. Immunol. 156, 1296ā1306.
Brard, F., Shannon, M., Prak, E. L., Litwin, S., and Weigert, M. (1999) Somatic mutation and light chain rearrangement generate autoimmunity in anti-single-stranded DNA transgenic MRL/lpr mice. J. Exp. Med. 190, 691ā704.
Fatenejad, S., Mamula, M. J., and Craft, J. (1993) Role of intermolecular/intrastructural B-and T-cell determinants in the diversification of autoantibodies to ribonucleoprotein particles. Proc. Natl. Acad. Sci. USA 90, 12,010ā12,014.
Scofield, R. H., Farris, A. D., Horsfall, A. C., and Harley, J. B. (1999) Fine specificity of the autoimmune response to the Ro/SSA and La/SSB ribonucleoproteins. Arthritis Rheum. 42, 199ā209.
Gay, D., Saunders, T., Camper, S., and Weigert, M. (1993) Receptor editing: an approach by autoreactive B cells to escape tolerance. J. Exp. Med. 177, 999ā1008.
Klonowski, K. D., Primiano, L. L., and Monestier, M. (1999) Atypical VH-D-JH rearrangements in newborn autoimmune MRL mice. J. Immunol. 162, 1566ā1572.
Klonowski, K. D. and Monestier, M. (2000) Heavy chain revision in MRL mice: a potential mechanism for the development of autoreactive B cell precursors. J. Immunol. 165, 4487ā4493.
Roark, J. H., Kuntz, C. L., Nguyen, K. A., Mandik, L., Cattermole, M., and Erikson, J. (1995) B cell selection and allelic exclusion of an anti-DNA Ig transgene in MRL-lpr/lpr mice. J. Immunol. 154, 4444ā4455.
Chen, C., Nagy, Z., Radic, M. Z., Hardy, R. R., Huszar, D., Camper, S. A., et al. (1995) The site and stage of anti-DNA B-cell deletion. Nature 373, 252ā255.
Santulli-Marotto, S., Retter, M. W., Gee, R., Mamula, M. J., and Clarke, S. H. (1998) Autoreactive B cell regulation: peripheral induction of developmental arrest by lupus-associated autoantigens. Immunity 8, 209ā219.
Santulli-Marotto, S., Qian, Y., Ferguson, S., and Clarke, S. H. (2001) Anti-Sm B cell differentiation in Ig transgenic MRL/Mp-lpr/lpr mice: altered differentiation and an accelerated response. J. Immunol. 166, 5292ā5299.
Ma, J., Xu, J., Madaio, M. P., Peng, Q., Zhang, J., Grewal, I. S., et al. (1996) Autoimmune lpr/lpr mice deficient in CD40 ligand: spontaneous Ig class switching with dichotomy of autoantibody responses. J. Immunol. 157, 417ā426.
Peng, S. L., Madaio, M. P., Hughes, D. P., Crispe, I. N., Owen, M. J., Wen, L., et al. (1996) Murine lupus in the absence of Ī±Ī² T cells. J. Immunol. 156,, 4041ā4049.
Peng, S. L., Madaio, M. P., Hayday, A. C., and Craft, J. (1996) Propagation and regulation of systemic autoimmunity by Ī³Ī“ T cells. J. Immunol. 157, 5689ā5698.
Peng, S. L., Fatenejad, S., and Craft, J. (1996) Induction of nonpathologic, humoral autoimmunity in lupus-prone mice by a class II-restricted, transgenic alpha beta T cell. Separation of autoantigen-specific and-nonspecific help. J. Immunol. 157, 5225ā5230.
Chan, O. T., Madaio, M. P., and Shlomchik, M. J. (1999) The central and multiple roles of B cells in lupus pathogenesis. Immunol. Rev. 169, 107ā121.
Peng, S. L., Moslehi, J., and Craft, J. (1997) Roles of interferon-Ī³ and interleukin-4 in murine lupus. J. Clin. Invest. 99, 1936ā1946.
Balomenos, D., Rumold, R., and Theofilopoulos, A. N. (1998) Interferon-Ī³ is required for lupus-like disease and lymphoaccumulation in MRL-lpr mice. J. Clin. Invest. 101, 364ā371.
Schwarting, A., Wada, T., Kinoshita, K., Tesch, G., and Kelley, V. R. (1998) IFN-Ī³ receptor signaling is essential for the initiation, acceleration, and destruction of autoimmune kidney disease in MRL-Fas(lpr) mice. J. Immunol. 161, 494ā503.
Tesch, G. H., Maifert, S., Schwarting, A., Rollins, B. J., and Kelley, V. R. (1999) Monocyte chemoattractant protein 1-dependent leukocytic infiltrates are responsible for autoimmune disease in MRL-Fas(lpr) mice. J. Exp. Med. 190, 1813ā1824.
Sekine, H., Reilly, C. M., Molano, I. D., Garnier, G., Circolo, A., Ruiz, P., et al. (2001) Complement component C3 is not required for full expression of immune complex glomerulonephritis in MRL/lpr mice. J. Immunol. 166, 6444ā6451.
Bao, L., Haas, M., Boackle, S. A., Kraus, D. M., Cunningham, P. N., Park, P., et al. (2002) Transgenic expression of a soluble complement inhibitor protects against renal disease and promotes survival in MRL/lpr mice. J. Immunol. 168, 3601ā3607.
Lloyd, C. M., Gonzalo, J. A., Salant, D. J., Just, J., and Gutierrez-Ramos, J. C. (1997) Intercellular adhesion molecule-1 deficiency prolongs survival and protects against the development of pulmonary inflammation during murine lupus. J. Clin. Invest. 100, 963ā971.
Tada, Y., Nagasawa, K., Ho, A., Morito, F., Koarada, S., Ushiyama, O., et al. (1999) Role of the costimulatory molecule CD28 in the development of lupus in MRL/lpr mice. J. Immunol. 163, 3153ā3159.
Kinoshita, K., Tesch, G., Schwarting, A., Maron, R., Sharpe, A. H., and Kelley, V. R. (2000) Costimulation by B7-1 and B7-2 is required for autoimmune disease in MRL-Faslpr mice. J. Immunol. 164, 6046ā6056.
Liang, B., Kashgarian, M. J., Sharpe, A. H., and Mamula, M. J. (2000) Autoantibody responses and pathology regulated by B7-1 and B7-2 costimulation in MRL/lpr lupus. J. Immunol. 165, 3436ā3443.
Jevnikar, A. M., Grusby, M. J., and Glimcher, L. H. (1994) Prevention of nephritis in major histocompatibility complex class II-deficient MRL-lpr mice. J. Exp. Med. 179, 1137ā1143.
Christianson, G. J., Blankenburg, R. L., Duffy, T. M., Panka, D., Roths, J. B., Marshak-Rothstein, A., et al. (1996) Ī²2-Microglobulin dependence of the lupus-like autoimmune syndrome of MRL-lpr mice. J. Immunol. 156, 4932ā4939.
Chan, O. T., Paliwal, V., McNiff, J. M., Park, S. H., Bendelac, A., and Shlomchik, M. J. (2001) Deficiency in Ī²2-microglobulin, but not CD1, accelerates spontaneous lupus skin disease while inhibiting nephritis in MRLFas(lpr) nice: an example of disease regulation at the organ level. J. Immunol. 167, 2985ā2990.
Watson, M. L., Rao, J. K., Gilkeson, G. S., Ruiz, P., Eicher, E. M., Pisetsky, D. S., et al. (1992) Genetic analysis of MRL-lpr mice: relationship of the Fas apoptosis gene to disease manifestations and renal disease-modifying loci. J. Exp. Med. 176, 1645ā1656.
Gu, L., Weinreb, A., Wang, X. P., Zack, D. J., Qiao, J. H., Weisbart, R., et al. (1998) Genetic determinants of autoimmune disease and coronary vasculitis in the MRL-lpr/lpr mouse model of systemic lupus erythematosus. J. Immunol. 161, 6999ā7006.
Vidal, S., Kono, D. H., and Theofilopoulos, A. N. (1998) Loci predisposing to autoimmunity in MRL-Fas lpr and C57BL/6-Faslpr mice. J. Clin. Invest. 101, 696ā702.
Nishihara, M., Terada, M., Kamogawa, J., Ohashi, Y., Mori, S., Nakatsuru, S., et al. (1999) Genetic basis of autoimmune sialadenitis in MRL/lpr lupus-prone mice: additive and hierarchical properties of polygenic inheritance. Arthritis Rheum. 42, 2616ā2623.
Kamogawa, J., Terada, M., Mizuki, S., Nishihara, M., Yamamoto, H., Mori, S., et al. (2002) Arthritis in MRL/lpr mice is under the control of multiple gene loci with an allelic combination derived from the original inbred strains. Arthritis Rheum. 46, 1067ā1074.
Kawase, E., Suemori, H., Takahashi, N., Okazaki, K., Hashimoto, K., and Nakatsuji, N. (1994) Strain difference in establishment of mouse embryonic stem (ES) cell lines. Int. J. Dev. Biol. 38, 385ā390.
Goulet, J. L., Wang, C. Y., and Koller, B. H. (1997) Embryonic stem cell lines from MRL mice allow genetic modification in a murine model of autoimmune disease. J. Immunol. 159, 4376ā4381.
Kelley, V. E. and Roths, J. B. (1985) Interaction of mutant lpr gene with background strain influences renal disease. Clin. Immunol. Immunopathol. 37, 220ā229.
Eisenberg, R. A., Craven, S. Y., Fisher, C. L., Morris, S. C., Rapoport, R., Pisetsky, D. S., et al. (1989) The genetics of autoantibody production in MRL/lpr lupus mice. Clin. Exp. Rheumatol. 7, S35āS40.
Peng, S. L. and Craft, J. (1999) Lessons from knockout and transgenic lupus-prone mice, in Lupus: Molecular and Cellular Pathogenesis (Kammer, G. M. and Tsokos, G. C., eds.), Humana Press, Totowa, NJ, pp. 152ā166.
Murphy, E. D. and Roths, J. B. (1979) A Y chromosome associated factor in strain BXSB producing accelerated autoimmunity and lymphoproliferation. Arthritis Rheum. 22, 1188ā1194.
Morel, L., Croker, B. P., Blenman, K. R., Mohan, C., Huang, G., Gilkeson, G., et al. (2000) Genetic reconstitution of systemic lupus erythematosus immunopathology with polycongenic murine strains. Proc. Natl. Acad. Sci. USA 97, 6670ā6675.
Izui, S., Masuda, K., and Yoshida, H. (1984) Acute SLE in F1 hybrids between SB/Le and NZW mice; prominently enhanced formation of gp70 immune complexes by a Y chromosome-associated factor from SB/Le mice. J. Immunol. 132, 701ā704.
Hudgins, C. C., Steinberg, R. T., Klinman, D. M., Reeves, M. J., and Steinberg, A. D. (1985) Studies of consomic mice bearing the Y chromosome of the BXSB mouse. J. Immunol. 134, 3849ā3854.
Izui, S., Higaki, M., Morrow, D., and Merino, R. (1988) The Y chromosome from autoimmune BXSB/MpJ mice induces a lupus-like syndrome in (NZW Ć C57BL/6) F1 male mice, but not in C57BL/6 male mice. Eur. J. Immunol. 18, 911ā915.
Hogarth, M. B., Slingsby, J. H., Allen, P. J., Thompson, E. M., Chandler, P., Davies, K. A., et al. (1998) Multiple lupus susceptibility loci map to chromosome 1 in BXSB mice. J. Immunol. 161, 2753ā2761.
Haywood, M. E., Hogarth, M. B., Slingsby, J. H., Rose, S. J., Allen, P. J., Thompson, E. M., et al. (2000) Identification of intervals on chromosomes 1, 3, and 13 linked to the development of lupus in BXSB mice. Arthritis Rheum. 43, 349ā355.
Maibaum, M. A., Haywood, M. E., Walport, M. J., and Morley, B. J. (2000) Lupus susceptibility loci map within regions of BXSB derived from the SB/Le parental strain. Immunogenetics 51, 370ā372.
Haywood, M. E., Vyse, T. J., McDermott, A., Thompson, E. M., Ida, A., Walport, M. J., et al. (2001) Autoantigen glycoprotein 70 expression is regulated by a single locus, which acts as a checkpoint for pathogenic anti-glycoprotein 70 autoantibody production and hence for the corresponding development of severe nephritis, in lupus-prone BXSB mice. J. Immunol. 167, 1728ā1733.
Hahn, B. H. and Ebling, F. M. (1984) A public idiotypic determinant is present on spontaneous cationic IgG antibodies to DNA from mice of unrelated lupus-prone strains. J. Immunol. 133, 3015ā3019.
Lawson, B. R., Koundouris, S. I., Barnhouse, M., Dummer, W., Baccala, R., Kono, D. H., et al. (2001) The role of Ī±Ī² T cells and homeostatic T cell proliferation in Y-chromosome-associated murine lupus. J. Immunol. 167, 2354ā2360.
Wofsy, D. (1986) Administration of monoclonal anti-T cell antibodies retards murine lupus in BXSB mice. J. Immunol. 136, 4554ā4560.
Chu, E. B., Hobbs, M. V., Wilson, C. B., Romball, C. G., Linsley, P. S., and Weigle, W. O. (1996) Intervention of CD4+ cell subset shifts and autoimmunity in the BXSB mouse by murine CTLA4Ig. J. Immunol. 156, 1262ā1268.
Adachi, Y., Inaba, M., Sugihara, A., Koshiji, M., Sugiura, K., Amoh, Y., et al. (1998) Effects of administration of monoclonal antibodies (anti-CD4 or anti-CD8) on the development of autoimmune diseases in (NZW Ć BXSB) F1 mice. Immunobiology 198, 451ā464.
Kono, D. H., Balomenos, D., Park, M. S., and Theofilopoulos, A. N. (2000) Development of lupus in BXSB mice is independent of IL-4. J. Immunol. 164, 38ā42.
Merino, R., Iwamoto, M., Fossati, L., Muniesa, P., Araki, K., Takahashi, S., et al. (1993) Prevention of systemic lupus erythematosus in autoimmune BXSB mice by a transgene encoding I-EĪ± chain. J. Exp. Med. 178, 1189ā1197.
Prudāhomme, G. J., Balderas, R. S., Dixon, F. J., and Theofilopoulos, A. N. (1983) B cell dependence on and response to accessory signals in murine lupus strains. J. Exp. Med. 157, 1815ā1827.
Umland, S. P., Go, N. F., Cupp, J. E., and Howard, M. (1989) Responses of B cells from autoimmune mice to IL-5. J. Immunol. 142, 1528ā1535.
Merino, R., Fossati, L., Lacour, M., and Izui, S. (1991) Selective autoantibody production by Yaa+ B cells in autoimmune Yaa(+)-Yaa-bone marrow chimeric mice. J. Exp. Med. 174, 1023ā1029.
Decker, P., Le Moal, A., Briand, J. P., and Muller, S. (2000) Identification of a minimal T cell epitope recognized by antinucleosome Th cells in the C-terminal region of histone H4. J. Immunol. 165, 654ā662.
Zhang, X., Smith, D. S., Guth, A., and Wysocki, L. J. (2001) A receptor presentation hypothesis for T cell help that recruits autoreactive B cells. J. Immunol. 166, 1562ā1571.
Ghatak, S., Sainis, K., Owen, F. L., and Datta, S. K. (1987) T-cell-receptor Ī²-and I-AĪ²-chain genes of normal SWR mice are linked with the development of lupus nephritis in NZB Ć SWR crosses. Proc. Natl. Acad. Sci. USA 84, 6850ā6853.
Xie, S., Chang, S., Yang, P., Jacob, C., Kaliyaperumal, A., Datta, S. K., et al. (2001) Genetic contributions of nonautoimmune SWR mice toward lupus nephritis. J. Immunol. 167, 7141ā7149.
Kalled, S. L., Cutler, A. H., Datta, S. K., and Thomas, D. W. (1998) Anti-CD40 ligand antibody treatment of SNF1 mice with established nephritis: preservation of kidney function. J. Immunol. 160, 2158ā2165.
Merino, R., Iwamoto, M., Gershwin, M. E., and Izui, S. (1994) The Yaa gene abrogates the major histocompatibility complex association of murine lupus in (NZB Ć BXSB) F1 hybrid mice. J. Clin. Invest. 94, 521ā525.
Hang, L. M., Izui, S., and Dixon, F. J. (1981) (NZW Ć BXSB) F1 hybrid. A model of acute lupus and coronary vascular disease with myocardial infarction. J. Exp. Med. 154, 216ā221.
Berden, J. H., Hang, L., McConahey, P. J., and Dixon, F. J. (1983) Analysis of vascular lesions in murine SLE. I. Association with serologic abnormalities. J. Immunol. 130, 1699ā1705.
Oyaizu, N., Yasumizu, R., Miyama-Inaba, M., Nomura, S., Yoshida, H., Miyawaki, S., et al. (1988) (NZW Ć BXSB) F1 mouse. A new animal model of idiopathic thrombocytopenic purpura. J. Exp. Med. 167, 2017ā2022.
Hashimoto, Y., Kawamura, M., Ichikawa, K., Suzuki, T., Sumida, T., Yoshida, S., et al. (1992) Anticardiolipin antibodies in NZW Ć BXSB F1 mice. A model of antiphospholipid syndrome. J. Immunol. 149, 1063ā1068.
Mizutani, H., Kurata, Y., Kosugi, S., Shiraga, M., Kashiwagi, H., Tomiyama, Y., et al. (1995) Monoclonal anticardiolipin autoantibodies established from the (New Zealand white Ć BXSB) F1 mouse model of antiphospholipid syndrome cross-react with oxidized low-density lipoprotein. Arthritis Rheum. 38, 1382ā1388.
Ida, A., Hirose, S., Hamano, Y., Kodera, S., Jiang, Y., Abe, M., et al. (1998) Multigenic control of lupus-associated antiphospholipid syndrome in a model of (NZW Ć BXSB) F1 mice. Eur. J. Immunol. 28, 2694ā2703.
Ibnou-Zekri, N., Iwamoto, M., Gershwin, M. E., and Izui, S. (2000) Protection of murine lupus by the Ead transgene is MHC haplotype-dependent. J. Immunol. 164, 505ā511.
Vidal, S., Gelpi, C., and Rodriguez-Sanchez, J. L. (1994) (SWR Ć SJL) F1 mice: a new model of lupus-like disease. J. Exp. Med. 179, 1429ā1435.
Yu, M., Johnson, J. M., and Tuohy, V. K. (1996) A predictable sequential determinant spreading cascade invariably accompanies progression of experimental autoimmune encephalomyelitis: a basis for peptide-specific therapy after onset of clinical disease. J. Exp. Med. 183, 1777ā1788.
Kinjoh, K., Kyogoku, M., and Good, R. A. (1993) Genetic selection for crescent formation yields mouse strain with rapidly progressive glomerulonephritis and small vessel vasculitis. Proc. Natl. Acad. Sci. USA 90, 3413ā3417.
Jethwa, H. S., Nachman, P. H., Falk, R. J., and Jennette, J. C. (2000) False-positive myeloperoxidase binding activity due to DNA/anti-DNA antibody complexes: a source for analytical error in serologic evaluation of anti-neutrophil cytoplasmic autoantibodies. Clin. Exp. Immunol. 121, 544ā550.
Portanova, J. P. and Kotzin, B. L. (1988) Lupus-like autoimmunity in murine graft-vs-host disease. Concepts Immunopathol. 6, 119ā140.
Silveira, P. A. and Baxter, A. G. (2001) The NOD mouse as a model of SLE. Autoimmunity 34, 53ā64.
Anderson, P. N. and Potter, M. (1969) Induction of plasma cell tumours in BALB-c mice with 2,6,10,14-tetramethylpentadecane (pristane). Nature 222, 994ā995.
Mock, B. A., Krall, M. M., and Dosik, J. K. (1993) Genetic mapping of tumor susceptibility genes involved in mouse plasmacytomagenesis. Proc. Natl. Acad. Sci. USA 90, 9499ā9503.
Zhang, S., Ramsay, E. S., and Mock, B. A. (1998) Cdkn2a, the cyclin-dependent kinase inhibitor encoding p16INK4a and p19ARF, is a candidate for the plasmacytoma susceptibility locus, Pctr1. Proc. Natl. Acad. Sci. USA 95, 2429ā2434.
Kovalchuk, A. L., Kim, J. S., Park, S. S., Coleman, A. E., Ward, J. M., Morse, H. C., 3rd, et al. (2002) IL-6 transgenic mouse model for extraosseous plasmacytoma. Proc. Natl. Acad. Sci. USA 99, 1509ā1514.
Potter, M. and Wax, J. S. (1981) Genetics of susceptibility to pristane-induced plasmacytomas in BALB/cAn: reduced susceptibility in BALB/cJ with a brief description of pristane-induced arthritis. J. Immunol. 127, 1591ā1595.
Wooley, P. H., Seibold, J. R., Whalen, J. D., and Chapdelaine, J. M. (1989) Pristane-induced arthritis. The immunologic and genetic features of an experimental murine model of autoimmune disease. Arthritis Rheum. 32, 1022ā1030.
Beech, J. T., Siew, L. K., Ghoraishian, M., Stasiuk, L. M., Elson, C. J., and Thompson, S. J. (1997) CD4+ Th2 cells specific for mycobacterial 65-kilodalton heat shock protein protect against pristane-induced arthritis. J. Immunol. 159, 3692ā3697.
Thompson, S. J., Francis, J. N., Siew, L. K., Webb, G. R., Jenner, P. J., Colston, M. J., et al. (1998) An immunodominant epitope from mycobacterial 65-kDa heat shock protein protects against pristane-induced arthritis. J. Immunol. 160, 4628ā4634.
Corrigall, V. M., Bodman-Smith, M. D., Fife, M. S., Canas, B., Myers, L. K., Wooley, P., et al. (2001) The human endoplasmic reticulum molecular chaperone BiP is an autoantigen for rheumatoid arthritis and prevents the induction of experimental arthritis. J. Immunol. 166, 1492ā1498.
Satoh, M. and Reeves, W. H. (1994) Induction of lupus-associated autoantibodies in BALB/c mice by intraperitoneal injection of pristane. J. Exp. Med. 180, 2341ā2346.
Satoh, M., Kumar, A., Kanwar, Y. S., and Reeves, W. H. (1995) Anti-nuclear antibody production and immune-complex glomerulonephritis in BALB/c mice treated with pristane. Proc. Natl. Acad. Sci. USA 92, 10,934ā10,938.
Satoh, M., Langdon, J. J., Hamilton, K. J., Richards, H. B., Panka, D., Eisenberg, R. A., et al. (1996) Distinctive immune response patterns of human and murine autoimmune sera to U1 small nuclear ribonucleoprotein C protein. J. Clin. Invest. 97, 2619ā2626.
Satoh, M., Richards, H. B., Shaheen, V. M., Yoshida, H., Shaw, M., Naim, J. O., et al. (2000) Widespread susceptibility among inbred mouse strains to the induction of lupus autoantibodies by pristane. Clin. Exp. Immunol. 121, 399ā405.
Richards, H. B., Satoh, M., Jennette, J. C., Croker, B. P., Yoshida, H., and Reeves, W. H. (2001) Interferon-Ī³ is required for lupus nephritis in mice treated with the hydrocarbon oil pristane. Kidney Int. 60, 2173ā2180.
Richards, H. B., Satoh, M., Shaw, M., Libert, C., Poli, V., and Reeves, W. H. (1998) Interleukin 6 dependence of anti-DNA antibody production: evidence for two pathways of autoantibody formation in pristane-induced lupus. J. Exp. Med. 188, 985ā990.
Satoh, M., Weintraub, J. P., Yoshida, H., Shaheen, V. M., Richards, H. B., Shaw, M., et al. (2000) Fas and Fas ligand mutations inhibit autoantibody production in pristane-induced lupus. J. Immunol. 165, 1036ā1043.
Satoh, M., Hamilton, K. J., Ajmani, A. K., Dong, X., Wang, J., Kanwar, Y. S., et al. (1996) Autoantibodies to ribosomal P antigens with immune complex glomerulonephritis in SJL mice treated with pristane. J. Immunol. 157, 3200ā3206.
Morse, H. C., 3rd, Riblet, R., Asofsky, R., and Weigert, M. (1978) Plasmacytomas of the NZB mouse. J. Immunol. 121, 1969ā1972.
Byrd, L. G., McDonald, A. H., Gold, L. G., and Potter, M. (1991) Specific pathogen-free BALB/cAn mice are refractory to plasmacytoma induction by pristane. J. Immunol. 147, 3632ā3637.
Mendlovic, S., Brocke, S., Shoenfeld, Y., Ben-Bassat, M., Meshorer, A., Bakimer, R., et al. (1988) Induction of a systemic lupus erythematosus-like disease in mice by a common human anti-DNA idiotype. Proc. Natl. Acad. Sci. USA 85, 2260ā2264.
Blank, M., Cohen, J., Toder, V., and Shoenfeld, Y. (1991) Induction of anti-phospholipid syndrome in naive mice with mouse lupus monoclonal and human polyclonal anti-cardiolipin antibodies. Proc. Natl. Acad. Sci. U S A 88, 3069ā3073.
Blank, M., Krause, I., Ben-Bassat, M., and Shoenfeld, Y. (1992) Induction of experimental anti-phospholipid syndrome associated with SLE following immunization with human monoclonal pathogenic anti-DNA idiotype. J. Autoimmun. 5, 495ā509.
Shoenfeld, Y. and Ziporen, L. (1998) Lessons from experimental APS models. Lupus 7, S158āS161.
Waisman, A., Ruiz, P. J., Israeli, E., Eilat, E., Konen-Waisman, S., Zinger, H., et al. (1997) Modulation of murine systemic lupus erythematosus with peptides based on complementarity determining regions of a pathogenic anti-DNA monoclonal antibody. Proc. Natl. Acad. Sci. USA 94, 4620ā4625.
Eilat, E., Dayan, M., Zinger, H., and Mozes, E. (2001) The mechanism by which a peptide based on complementarity-determining region-1 of a pathogenic anti-DNA auto-Ab ameliorates experimental systemic lupus erythematosus. Proc. Natl. Acad. Sci. USA 98, 1148ā1153.
Mozes, E., Kohn, L. D., Hakim, F., and Singer, D. S. (1993) Resistance of MHC class I-deficient mice to experimental systemic lupus erythematosus. Science 261, 91ā93.
Segal, R., Dayan, M., Zinger, H., and Mozes, E. (2001) Suppression of experimental systemic lupus erythematosus (SLE) in mice via TNF inhibition by an anti-TNFĪ± monoclonal antibody and by pentoxiphylline. Lupus 10, 23ā31.
Isenberg, D. A., Katz, D., Le Page, S., Knight, B., Tucker, L., Maddison, P., et al. (1991) Independent analysis of the 16/6 idiotype lupus model. A role for an environmental factor? J. Immunol. 147, 4172ā4177.
Watanabe-Fukunaga, R., Brannan, C. I., Copeland, N. G., Jenkins, N. A., and Nagata, S. (1992) Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 356, 314ā317.
Adachi, M., Watanabe-Fukunaga, R., and Nagata, S. (1993) Aberrant transcription caused by the insertion of an early transposable element in an intron of the Fas antigen gene of lpr mice. Proc. Natl. Acad. Sci. USA 90, 1756ā1760.
Chu, J. L., Drappa, J., Parnassa, A., and Elkon, K. B. (1993) The defect in Fas mRNA expression in MRL/lpr mice is associated with insertion of the retrotransposon, ETn. J. Exp. Med. 178, 723ā730.
Wu, J., Zhou, T., He, J., and Mountz, J. D. (1993) Autoimmune disease in mice due to integration of an endogenous retrovirus in an apoptosis gene. J. Exp. Med. 178, 461ā468.
Roths, J. B., Murphy, E. D., and Eicher, E. M. (1984) A new mutation, gld, that produces lymphoproliferation and autoimmunity in C3H/HeJ mice. J. Exp. Med. 159, 1ā20.
Lynch, D. H., Watson, M. L., Alderson, M. R., Baum, P. R., Miller, R. E., Tough, T., et al. (1994) The mouse Fas-ligand gene is mutated in gld mice and is part of a TNF family gene cluster. Immunity 1, 131ā136.
Takahashi, T., Tanaka, M., Brannan, C. I., Jenkins, N. A., Copeland, N. G., Suda, T., et al. (1994) Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell 76, 969ā976.
Matsuzawa, A., Moriyama, T., Kaneko, T., Tanaka, M., Kimura, M., Ikeda, H., et al. (1990) A new allele of the lpr locus, lprcg, that complements the gld gene in induction of lymphadenopathy in the mouse. J. Exp. Med. 171, 519ā531.
Kimura, M., Mohri, H., Shimada, K., Wakabayashi, T., Kanai, Y., and Matsuzawa, A. (1990) Serological and histological characterization of the new mutant strain of lpr mice, CBA/KlJms-lprcg/lprcg. Clin. Exp. Immunol. 79, 123ā129.
Kimura, M., Katagiri, T., Kikuchi, Y., Shimada, K., Nariuchi, H., Wakabayashi, T., et al. (1991) Role of bone marrow cells in autoantibody production and lymphoproliferation in the novel mutant strain of mice, CBA/KlJms-lprcg/lprcg. Eur. J. Immunol. 21, 63ā69.
Kimura, M., Ikeda, H., Katagiri, T., and Matsuzawa, A. (1991) Characterization of lymphoproliferation induced by interactions between lprcg and gld genes. Cell. Immunol. 134, 359ā369.
Matsuzawa, A., Kimura, M., Muraiso, T., Kominami, R., and Katagiri, T. (1991) Genotype-restricted lymphoproliferation in autoimmune lpr mice. Eur. J. Immunol. 21, 1535ā1542.
Kimura, M., Ogata, Y., Shimada, K., Moriyama, T., and Matsuzawa, A. (1991) New mutant mice of autoimmunity, CBA/KiJms-lprcg/lprcg, that could link the lpr and gld genes. Autoimmunity 9, 359ā361.
Adachi, M., Suematsu, S., Suda, T., Watanabe, D., Fukuyama, H., Ogasawara, J., et al. (1996) Enhanced and accelerated lymphoproliferation in Fas-null mice. Proc. Natl. Acad. Sci. USA 93, 2131ā2136.
Senju, S., Negishi, I., Motoyama, N., Wang, F., Nakayama, K. I., Nakayama, K., et al. (1996) Functional significance of the Fas molecule in naive lymphocytes. Int. Immunol. 8,423ā431.
Fisher, G. H., Rosenberg, F. J., Straus, S. E., Dale, J. K., Middleton, L. A., Lin, A. Y., et al. (1995) Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell 81, 935ā946.
Rieux-Laucat, F., Le Deist, F., Hivroz, C., Roberts, I. A., Debatin, K. M., Fischer, A., et al. (1995) Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity. Science 268, 1347ā1349.
Drappa, J., Vaishnaw, A. K., Sullivan, K. E., Chu, J. L., and Elkon, K. B. (1996) Fas gene mutations in the Canale-Smith syndrome, an inherited lymphoproliferative disorder associated with autoimmunity. N. Engl. J. Med. 335, 1643ā1649.
Wu, J., Wilson, J., He, J., Xiang, L., Schur, P. H., and Mountz, J. D. (1996) Fas ligand mutation in a patient with systemic lupus erythematosus and lymphoproliferative disease. J. Clin. Invest. 98, 1107ā1113.
Wang, J., Zheng, L., Lobito, A., Chan, F. K., Dale, J., Sneller, M., et al. (1999) Inherited human Caspase 10 mutations underlie defective lymphocyte and dendritic cell apoptosis in autoimmune lymphoproliferative syndrome type II. Cell 98, 47ā58.
Roark, J. H., Kuntz, C. L., Nguyen, K. A., Caton, A. J., and Erikson, J. (1995) Breakdown of B cell tolerance in a mouse model of systemic lupus erythematosus. J. Exp. Med. 181, 1157ā1167.
Mandik-Nayak, L., Seo, S. J., Sokol, C., Potts, K. M., Bui, A., and Erikson, J. (1999) MRL-lpr/lpr mice exhibit a defect in maintaining developmental arrest and follicular exclusion of anti-double-stranded DNA B cells. J. Exp. Med. 189, 1799ā1814.
Seo, S. J., Fields, M. L., Buckler, J. L., Reed, A. J., Mandik-Nayak, L., Nish, S. A., et al. (2002) The impact of T helper and T regulatory cells on the regulation of anti-double-stranded DNA B cells. Immunity 16, 535ā546.
Theofilopoulos, A. N., Balderas, R. S., Gozes, Y., Aguado, M. T., Hang, L. M., Morrow, P. R., et al. (1985) Association of lpr gene with graft-vs-host disease-like syndrome. J. Exp. Med. 162, 1ā18.
Kurien, B. T. and Scofield, R. H. (1999) Mouse urine collection using clear plastic wrap. Lab. Anim. 33, 83ā86.
Kimura, M., Nagase, M., Hishida, A., and Honda, N. (1987) Intramesangial passage of mononuclear phagocytes in murine lupus glomerulonephritis. Am. J. Pathol. 127, 149ā156.
Hoffsten, P. E., Hill, C. L., and Klahr, S. (1975) Studies of abluminuria and proteinuria in normal mice and mice with immune complex glomerulonephritis. J. Lab. Clin. Med. 86, 920ā930.
Hem, A., Smith, A. J., and Solberg, P. (1998) Saphenous vein puncture for blood sampling of the mouse, rat, hamster, gerbil, guinea pig, ferret and mink. Lab. Anim. 32, 364ā368.
Furner, R. L. and Mellett, L. B. (1975) Mouse restraining chamber for tail-vein injection. Lab. Anim. Sci. 25, 648.
Durschlag, M., Wurbel, H., Stauffacher, M., and Von Holst, D. (1996) Repeated blood collection in the laboratory mouse by tail incisionāmodification of an old technique. Phys. Behav. 60, 1565ā1568.
Hijmans, W., Radema, H., van Es, L., Feltkamp, T. E., van Loghem, J. J., and Schaap, O. L. (1969) Cryoglobulins in New Zealand black mice. Clin. Exp. Immunol. 4, 227ā239.
Reininger, L., Berney, T., Shibata, T., Spertini, F., Merino, R., and Izui, S. (1990) Cryoglobulinemia induced by a murine IgG3 rheumatoid factor: skin vasculitis and glomerulonephritis arise from distinct pathogenic mechanisms. Proc. Natl. Acad. Sci. USA 87, 10,038ā10,042.
Dammacco, F., Sansonno, D., Piccoli, C., Tucci, F. A., and Racanelli, V. (2001) The cryoglobulins: an overview. Eur. J. Clin. Invest. 31, 628ā638.
Peng, S. L. and Craft, J. (2001) Antinuclear antibodies, in Kellyās Textbook of Rheumatology (Ruddy, S., Harris, E. D., and Sledge, C. B., eds.), Saunders, Philadelphia, PA, pp. 161ā174.
Shlomchik, M. J., Madaio, M. P., Ni, D., Trounstein, M., and Huszar, D. (1994) The role of B cells in lpr/lpr-induced autoimmunity. J. Exp. Med. 180, 1295ā1306.
Peng, S. L., Cappadona, J., McNiff, J. M., Madaio, M. P., Owen, M. J., Hayday, A. C., et al. (1998) Pathogenesis of autoimmunity in Ī±Ī² T cell-deficient lupus-prone mice. Clin. Exp. Immunol. 111, 107ā116.
Kofler, R., Perlmutter, R. M., Noonan, D. J., Dixon, F. J., and Theofilopoulos, A. N. (1985) Ig heavy chain variable region gene complex of lupus mice exhibits normal restriction fragment length polymorphism. J. Exp. Med. 162, 346ā351.
Kotzin, B. L., Barr, V. L., and Palmer, E. (1985) A large deletion within the T-cell receptor Ī²-chain gene complex in New Zealand white mice. Science 229, 167ā171.
Noonan, D. J., Kofler, R., Singer, P. A., Cardenas, G., Dixon, F. J., and Theofilopoulos, A. N. (1986) Delineation of a defect in T cell receptor Ī² genes of NZW mice predisposed to autoimmunity. J. Exp. Med. 163, 644ā653.
Yanagi, Y., Hirose, S., Nagasawa, R., Shirai, T., Mak, T. W., and Tada, T. (1986) Does the deletion within T cell receptor Ī²-chain gene of NZW mice contribute to autoimmunity in (NZB Ć NZW) F1 mice? Eur. J. Immunol. 16, 1179ā1182.
Singer, P. A., McEvilly, R. J., Balderas, R. S., Dixon, F. J., and Theofilopoulos, A. N. (1988) T-cell receptor Ī±-chain variable-region haplotypes of normal and autoimmune laboratory mouse strains. Proc. Natl. Acad. Sci. USA 85, 7729ā7733.
Wilson, R. K., Lai, E., Concannon, P., Barth, R. K., and Hood, L. E. (1988) Structure, organization and polymorphism of murine and human T-cell receptor Ī± and Ī² chain gene families. Immunol. Rev. 101, 149ā172.
Jouvin-Marche, E., Morgado, M. G., Trede, N., Marche, P. N., Couez, D., Hue, I., et al. (1989) Complexity, polymorphism, and recombination of mouse T-cell receptor Ī± gene families. Immunogenetics 30, 99ā104.
Klotz, J. L., Barth, R. K., Kiser, G. L., Hood, L. E., and Kronenberg, M. (1989) Restriction fragment length polymorphisms of the mouse T-cell receptor gene families. Immunogenetics 29, 191ā201.
Theofilopoulos, A. N., Kofler, R., Singer, P. A., and Dixon, F. J. (1989) Molecular genetics of murine lupus models. Adv. Immunol. 46, 61ā109.
Noonan, D. J., McConahey, P. J., and Cardenas, G. J. (1990) Correlations of autoimmunity with H-2 and T cell receptor Ī² chain genotypes in (NZB Ć NZW) F2 mice. Eur. J. Immunol. 20, 1105ā1110.
Hansen, T. H., Carreno, B. M., and Sachs, D. H. (1993) The major histocompatibility complex, in Fundamental Immunology (Paul, W. E., ed.), Raven Press, New York, pp. 577ā628.
Choi, Y., Ramnath, V. R., Eaton, A. S., Chen, A., Simon-Stoos, K. L., Kleiner, D. E., et al. (1999) Expression in transgenic mice of dominant interfering Fas mutations: a model for human autoimmune lymphoproliferative syndrome. Clin. Immunol. 93, 34ā45.
Balomenos, D., Martin-Caballero, J., Garcia, M. I., Prieto, I., Flores, J. M., Serrano, M., et al. (2000) The cell cycle inhibitor p21 controls T-cell proliferation and sex-linked lupus development. Nat. Med. 6, 171ā176.
Lawson, B. R., Kono, D. H., and Theofilopoulos, A. N. (2002) Deletion of p21 (WAF-1/Cip1) does not induce systemic autoimmunity in female BXSB mice. J. Immunol. 168, 5928ā5932.
Strasser, A., Whittingham, S., Vaux, D. L., Bath, M. L., Adams, J. M., Cory, S., et al. (1991) Enforced BCL2 expression in B-lymphoid cells prolongs antibody responses and elicits autoimmune disease. Proc. Natl. Acad. Sci. USA 88, 8661ā8665.
Bouillet, P., Metcalf, D., Huang, D. C., Tarlinton, D. M., Kay, T. W., Kontgen, F., et al. (1999) Proapoptotic Bcl-2 relative Bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity. Science 286, 1735ā1738.
Bouillet, P., Purton, J. F., Godfrey, D. I., Zhang, L. C., Coultas, L., Puthalakath, H., et al. (2002) BH3-only Bcl-2 family member Bim is required for apoptosis of autoreactive thymocytes. Nature 415, 922ā926.
Murga, M., Fernandez-Capetillo, O., Field, S. J., Moreno, B., Borlado, L. R., Fujiwara, Y., et al. (2001) Mutation of E2F2 in mice causes enhanced T lymphocyte proliferation, leading to the development of autoimmunity. Immunity 15, 959ā970.
Salvador, J. M., Hollander, M. C., Nguyen, A. T., Kopp, J. B., Barisoni, L., Moore, J. K., et al. (2002) Mice lacking the p53-effector gene Gadd45a develop a lupus-like syndrome. Immunity 16, 499ā508.
Di Cristofano, A., Kotsi, P., Peng, Y. F., Cordon-Cardo, C., Elkon, K. B., and Pandolfi, P. P. (1999) Impaired Fas response and autoimmunity in Pten Ā± mice. Science 285, 2122ā2125.
Suzuki, A., Yamaguchi, M. T., Ohteki, T., Sasaki, T., Kaisho, T., Kimura, Y., et al. (2001) T cell-specific loss of Pten leads to defects in central and peripheral tolerance. Immunity 14, 523ā534.
Yoshinaga, S. K., Zhang, M., Pistillo, J., Horan, T., Khare, S. D., Miner, K., et al. (2000) Characterization of a new human B7-related protein: B7RP-1 is the ligand to the co-stimulatory protein ICOS. Int. Immunol. 12, 1439ā1447.
Prodeus, A. P., Goerg, S., Shen, L. M., Pozdnyakova, O. O., Chu, L., Alicot, E. M., et al. (1998) A critical role for complement in maintenance of self-tolerance. Immunity 9, 721ā731.
OāKeefe, T. L., Williams, G. T., Davies, S. L., and Neuberger, M. S. (1996) Hyperresponsive B cells in CD22-deficient mice. Science 274, 798ā801.
Majeti, R., Xu, Z., Parslow, T. G., Olson, J. L., Daikh, D. I., Killeen, N., et al. (2000) An inactivating point mutation in the inhibitory wedge of CD45 causes lymphoproliferation and autoimmunity. Cell 103, 1059ā1070.
Tivol, E. A., Borriello, F., Schweitzer, A. N., Lynch, W. P., Bluestone, J. A., and Sharpe, A. H. (1995) Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity 3, 541ā547.
Waterhouse, P., Penninger, J. M., Timms, E., Wakeham, A., Shahinian, A., Lee, K. P., et al. (1995) Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4. Science 270, 985ā988.
Bolland, S. and Ravetch, J. V. (2000) Spontaneous autoimmune disease in FcĪ³RIIB-deficient mice results from strain-specific epistasis. Immunity 13, 277ā285.
Le, L. Q., Kabarowski, J. H., Weng, Z., Satterthwaite, A. B., Harvill, E. T., Jensen, E. R., et al. (2001) Mice lacking the orphan G protein-coupled receptor G2A develop a late-onset autoimmune syndrome. Immunity 14, 561ā571.
Suzuki, H., Kundig, T. M., Furlonger, C., Wakeham, A., Timms, E., Matsuyama, T., et al. (1995) Deregulated T cell activation and autoimmunity in mice lacking interleukin-2 receptor Ī². Science 268, 1472ā1476.
Nishimura, H., Nose, M., Hiai, H., Minato, N., and Honjo, T. (1999) Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor. Immunity 11, 141ā151.
Wen, L., Roberts, S. J., Viney, J. L., Wong, F. S., Mallick, C., Findly, R. C., et al. (1994) Immunoglobulin synthesis and generalized autoimmunity in mice congenitally deficient in Ī±Ī²(+) T cells. Nature 369, 654ā658.
Wang, J. H., Avitahl, N., Cariappa, A., Friedrich, C., Ikeda, T., Renold, A., et al. (1998) Aiolos regulates B cell activation and maturation to effector state. Immunity 9, 543ā553.
Nash, J. T., Taylor, P. R., Botto, M., Norsworthy, P. J., Davies, K. A., and Walport, M. J. (2001) Immune complex processing in C1q-deficient mice. Clin. Exp. Immunol. 123, 196ā202.
Botto, M., DellāAgnola, C., Bygrave, A. E., Thompson, E. M., Cook, H. T., Petry, F., et al. (1998) Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies. Nat. Genet. 19, 56ā59.
Mackay, F., Woodcock, S. A., Lawton, P., Ambrose, C., Baetscher, M., Schneider, P., et al. (1999) Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations. J. Exp. Med. 190, 1697ā1710.
Gross, J. A., Johnston, J., Mudri, S., Enselman, R., Dillon, S. R., Madden, K., et al. (2000) TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease. Nature 404, 995ā999.
Khare, S. D., Sarosi, I., Xia, X. Z., McCabe, S., Miner, K., Solovyev, I., et al. (2000) Severe B cell hyperplasia and autoimmune disease in TALL-1 transgenic mice. Proc. Natl. Acad. Sci. USA 97, 3370ā3375.
Krawczyk, C., Bachmaier, K., Sasaki, T., Jones, G. R., Snapper, B. S., Bouchard, D., et al. (2000) Cbl-b is a negative regulator of receptor clustering and raft aggregation in T cells. Immunity 13, 463ā473.
Zhang, Y., Schlossman, S. F., Edwards, R. A., Ou, C. N., Gu, J., and Wu, M. X. (2002) Impaired apoptosis, extended duration of immune responses, and a lupus-like autoimmune disease in IEX-1-transgenic mice. Proc. Natl. Acad. Sci. USA 99, 878ā883.
Hibbs, M. L., Tarlinton, D. M., Armes, J., Grail, D., Hodgson, G., Maglitto, R., et al. (1995) Multiple defects in the immune system of Lyn-deficient mice, culminating in autoimmune disease. Cell 83, 301ā311.
Nishizumi, H., Taniuchi, I., Yamanashi, Y., Kitamura, D., Ilic, D., Mori, S., et al. (1995) Impaired proliferation of peripheral B cells and indication of autoimmune disease in lyn-deficient mice. Immunity 3, 549ā560.
Cornall, R. J., Cyster, J. G., Hibbs, M. L., Dunn, A. R., Otipoby, K. L., Clark, E. A., et al. (1998) Polygenic autoimmune traits: Lyn, CD22, and SHP-1 are limiting elements of a biochemical pathway regulating BCR signaling and selection. Immunity 8, 497ā508.
Scott, R. S., McMahon, E. J., Pop, S. M., Reap, E. A., Caricchio, R., Cohen, P. L., et al. (2001) Phagocytosis and clearance of apoptotic cells is mediated by MER. Nature 411, 207ā211.
Demetriou, M., Granovsky, M., Quaggin, S., and Dennis, J. W. (2001) Negative regulation of T-cell activation and autoimmunity by Mgat5 N-glycosylation. Nature 409, 733ā739.
Sun, H., Lu, B., Li, R. Q., Flavell, R. A., and Taneja, R. (2001) Defective T cell activation and autoimmune disorder in Stra13-deficient mice. Nat. Immunol. 2, 1040ā1047.
Yaswen, L., Kulkarni, A. B., Fredrickson, T., Mittleman, B., Schiffman, R., Payne, S., et al. (1996) Autoimmune manifestations in the transforming growth factor-Ī²1 knockout mouse. Blood 87, 1439ā1445.
Gorelik, L. and Flavell, R. A. (2000) Abrogation of TGFĪ² signaling in T cells leads to spontaneous T cell differentiation and autoimmune disease. Immunity 12, 171ā181.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
Ā© 2004 Humana Press Inc., Totowa, NJ
About this protocol
Cite this protocol
Peng, S.L. (2004). Experimental Use of Murine Lupus Models. In: Perl, A. (eds) Autoimmunity. Methods in Molecular Medicineā¢, vol 102. Humana Press. https://doi.org/10.1385/1-59259-805-6:227
Download citation
DOI: https://doi.org/10.1385/1-59259-805-6:227
Publisher Name: Humana Press
Print ISBN: 978-1-58829-231-5
Online ISBN: 978-1-59259-805-2
eBook Packages: Springer Protocols